News
-
December 1, 2011
Critical Path Institute Gathers Cross-Sector Innovators at Global Conference on Drug Development
Hundreds of leaders from cross-sector arenas in government, academia, the biotechnology and pharmaceutical industry, and patient advocacy organizations gathered over the past two days at Critical Path Institute’s Creating Consensus Science: Tools and Tactics for Next-Gen Drug Development conference to articulate a common commitment to the future of global collaborative efforts that develop innovative tools... -
November 9, 2011
CPTR Yields Progress: New Five-Way Agreement Among Pharmas and NGOs will Speed Development of TB Drug Combinations
The Critical Path to TB Drug Regimens (CPTR) today announced an innovative agreement between AstraZeneca, Sanofi, Tibotec, TB Alliance, and the World Health Organization to share information on tuberculosis (TB) compounds within their respective drug pipelines to quickly identify and work together to develop the most promising TB drug regimen, regardless of sponsor. Previously, development... -
November 1, 2011
C-Path Joins Leading Voices and Organizations in Alzheimer’s Research, Drug Discovery and Care to Call for Dramatic New Strategy to Stop Alzheimer’s Disease in Report Out Today
Leaders Engaged on Alzheimer’s Disease (LEAD) was created in February 2008 as an open network of Alzheimer’s-serving organizations to link key stakeholders from the government, business, and civic sectors to increase attention to and awareness of Alzheimer’s disease, its care, treatment, prevention, research, and eventual cure. -
October 28, 2011
C-Path’s Avilés Discusses Importance of Data Standards in FDA Week Article
FDA is encouraging industry to use newly crafted therapeutic data standards — such as utilization of qualified biomarkers– in submissions and could start requiring companies to use the standardized data elements in the future,sources said following the release of the first set of standardized therapeutic data elements for Alzheimer’s disease that they said could make... -
October 17, 2011
Critical Path Institute and Clinical Data Interchange Standards Consortium Announce Release of Data Standards for Alzheimer’s Disease Research
Critical Path Institute(C-Path)and Clinical Data Interchange Standards Consortium(CDISC) today announced the release of version 1.0 of the Alzheimer’s disease (AD) Therapeutic Area Standard(SDTM AD/Mild Cognitive Impairment User Guide). This was developed for the clinical research community to facilitate analysis and learning from clinical studies for treatment or prevention of AD.